Mycobacteria are highly potent adjuvants; therefore, expression of for
eign genes in mycobacteria provides a delivery system to induce strong
immune responses against foreign proteins. In this study we report tr
ansformation of Mycobacterium smegmatis by homologous recombination us
ing pUC19-based plasmid vectors with pyrF gene of M. smegmatis (pY6001
) or pyrF gene disrupted by introducing the aminoglycoside phosphotran
sferase (aph) gene (pY6002). Both of these plasmids were used to trans
form the host cells by electroporation. The transformation and selecti
on conditions were optimized with respect to cell number, stage of cel
l growth, DNA concentration, postelectroporation incubation time, and
kanamycin concentration, With the plasmid Y6002, the transformation wa
s usually a result of single crossover (class I transformants) and onl
y 5% transformants were generated by double crossover (class II transf
ormants). The double crossover led to the replacement of wild-type pyr
F gene with the aph-disrupted pyrF gene. The gene replacement could al
so occur by resolution of the class I transformants into class II, but
at a very low frequency. Further experiments were done to determine i
f the wild-type genotype could be rescued by retransformation with pY6
001. Similar transformation efficiencies, as reported above, were obta
ined, but the frequency of double crossover increased to 35%. This tra
nsformation strategy provides a way by which the mycobacteria transfor
med with foreign genes will not require drug selection, a trait prefer
red to develop recombinant vaccines.